Scholarlink

Background <p>Stomach adenocarcinoma (STAD) is one of most common cancers with high invasiveness and poor prognosis. Obesity and aging are correlated with higher risk for cancer development and worse prognosis in certain types of malignancies.</p> Methods <p>An integrative approach incorporating 10 machine learning methods was employed to develop an obesity and aging-related signature (ORS) using data from the TCGA, GSE15459, GSE26253, GSE62254, and GSE84437 datasets. To assess the predictive value of ORS for immunotherapy benefits, we utilized several indicating scores and three immunotherapy datasets (GSE91061, GSE78220, and IMvigor210).</p> Results <p>The predictive model developed using the LASSO method achieved the highest average C-index and was identified as the optimal ORS. This ORS served as an independent risk factor for the clinical outcomes of STAD patients, demonstrating robust performance in predicting overall survival rates. In the TCGA cohort, the area under the curve values for the 1-, 3-, and 5-year receiver operator characteristic curves were 0.871, 0.803, and 0.768, respectively. Patients with low ORS score exhibited higher gene set scores for immune-activated cells, increased cytolytic activity, and enhanced T cell co-stimulation. Additionally, low ORS score was associated with a reduced tumor immune dysfunction and exclusion score, decreased immune escape score, elevated PD1 and CTLA4 immunophenoscore, higher tumor mutation burden, improved response rates, and better prognosis in STAD. Conversely, the IC50 values for common chemotherapy and targeted therapy regimens were lower in the high ORS score group.</p> Conclusion <p>The current study developed an optimal ORS in STAD, which could be used for predicting the prognosis, stratifying risk and guiding treatment for STAD patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Machine learning based obesity and aging related signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月1日

查看全文
  • Yongheng Chen,
  • Xiaoxia Yu,
  • Wencan Xu,
  • Anqi Huang,
  • Zhengbing Li

摘要

Background

Stomach adenocarcinoma (STAD) is one of most common cancers with high invasiveness and poor prognosis. Obesity and aging are correlated with higher risk for cancer development and worse prognosis in certain types of malignancies.

Methods

An integrative approach incorporating 10 machine learning methods was employed to develop an obesity and aging-related signature (ORS) using data from the TCGA, GSE15459, GSE26253, GSE62254, and GSE84437 datasets. To assess the predictive value of ORS for immunotherapy benefits, we utilized several indicating scores and three immunotherapy datasets (GSE91061, GSE78220, and IMvigor210).

Results

The predictive model developed using the LASSO method achieved the highest average C-index and was identified as the optimal ORS. This ORS served as an independent risk factor for the clinical outcomes of STAD patients, demonstrating robust performance in predicting overall survival rates. In the TCGA cohort, the area under the curve values for the 1-, 3-, and 5-year receiver operator characteristic curves were 0.871, 0.803, and 0.768, respectively. Patients with low ORS score exhibited higher gene set scores for immune-activated cells, increased cytolytic activity, and enhanced T cell co-stimulation. Additionally, low ORS score was associated with a reduced tumor immune dysfunction and exclusion score, decreased immune escape score, elevated PD1 and CTLA4 immunophenoscore, higher tumor mutation burden, improved response rates, and better prognosis in STAD. Conversely, the IC50 values for common chemotherapy and targeted therapy regimens were lower in the high ORS score group.

Conclusion

The current study developed an optimal ORS in STAD, which could be used for predicting the prognosis, stratifying risk and guiding treatment for STAD patients.